Atlas Trials

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

Clinical trial NCT00237016 · COMPLETED

Trial details

NCT number
NCT00237016
Sponsor
Medical Corps, Israel Defense Force
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Relapsing Fever, Tick-borneJarisch Herxheimer Reaction
Start date
2002-04-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.